A Phase 3, Double Blind, Placebo Controlled Trial and Long Term Safety Extension of Obeticholic Acid in Patients with Primary Biliary Cirrhosis
A Phase 3, Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency.
A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
A Phase 3/4, Multi-Center, Randomized, Double-Blind,
Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab
(HGS1006) in Adult Subjects of Black Race with Systemic Lupus Erythematosus (SLE).
A Phase I Therapeutic Dose Escalation Study using Percutaneous Image-Guided Navigation for High Dose Rate Brachyablation of Primary Liver Lesions
A Phase II Open-label, Multicenter Extension Study to Assess the Long-term Safety and Efficacy of Vamorolone in Boys with Duchenne Muscular Dystrophy (DMD)
A Phase II Single-Arm Study of Atezolizumab Monotherapy In Locally Advanced Or Metastatic Non-Small Cell Lung Cancer: Clinical Evaluation Of Novel Blood-Based Diagnostics
A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors
A Phase II Trial of Rituximab In Myasthenia Gravis (NN103)
A Phase III Open-LabelRandomized Clinical Trial to Study the Efficacy and Safety of the
Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic
HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy.